Component

Human PPAR gamma / PPARG

Human PPAR gamma / PPARG. Species, exposure and limitations are retained in each linked claim.

16 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Luteolin reduced IL-8 release and restored electrical resistance in hypertonic human corneal epithelial cultures through a PPAR gamma-dependent response.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human corneal epithelial cell culture.
    limitations
    Not an oral dry-eye treatment trial.
    nutrient_topic
    Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
    plain_language
    An eye-surface model links inflammation and barrier function.
    primary_references
    Mode of peroxisome proliferator-activated receptor γ activation by luteolin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22391103/ · DOI 10.1124/mol.111.076216

    Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 380–386

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human corneal epithelial cell culture. · source_derived_draft · unverified_draft

    ## luteolin-pparg-corneal An eye-surface model links inflammation and barrier function. Luteolin reduced IL-8 release and restored electrical resistance in hypertonic human corneal epithelial cultures through a PPAR gamma-dependent response. Model: Human corneal epithelial cell culture. Limitations: Not an oral dry-eye treatment trial. Evidence access: Primary abstract Mode of peroxisome proliferator-activated receptor γ activation by luteolin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22391103/ · DOI 10.1124/mol.111.076216
    Complete structured claim and evidence
  2. Ibuprofen activates peroxisome proliferator-activated receptor gamma in neuron-like PC12 and B104 cells, activation with traditional agonists mimics the RhoA-inhibiting properties of ibuprofen and promotes neurite elongation in primary neurons exposed to axonal growth inhibitors, small interfering RNA against the receptor blocks RhoA suppression by those agonists, and selective receptor inhibition prevents the effect of ibuprofen on RhoA activity and neurite growth, supporting an essential role for the receptor in coupling ibuprofen to RhoA inhibition.

    Human PPAR gamma / PPARG → RhoA source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/ibuprofen-research/20089905.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77e2dbb010dcee44bd66645ec26cb844d7041ea4930f6373ae5dd6b10da37df3", "start_char": 0, "end_char": 1812, "text_sha256": "77e2dbb010dcee44bd66645ec26cb844d7041ea4930f6373ae5dd6b10da37df3"}
    experimental_model
    Neuron-like PC12 and B104 cells and primary cultured neurons with small interfering RNA knockdown
    exposure
    Ibuprofen with peroxisome proliferator-activated receptor gamma agonists, antagonists and knockdown
    limitations
    The knockdown and the selective antagonist together make the receptor requirement a test rather than a correlation. Cell lines and primary culture rather than an animal.
    nutrient_topic
    Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. · Ibuprofen
    organism
    Rat
    plain_language
    The drug reaches a growth-blocking switch in neurons through a fat-sensing receptor, not through prostaglandins.
    primary_references
    [ibu-p20089905] A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. (2010). https://pubmed.ncbi.nlm.nih.gov/20089905/ DOI: 10.1523/jneurosci.5045-09.2010
    tissue_or_cell_type
    Neurons

    Ibuprofen: the enantiomer that works, the one that was called inactive, the one-way chemistry that turns one into the other, and the targets that are not cyclooxygenase (2026-09-22) · lines 422–433

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Neuron-like PC12 and B104 cells and primary cultured neurons with small interfering RNA knockdown · source_derived_draft · unverified_draft

    ### ibu-pparg-couples-to-rhoa Ibuprofen activates peroxisome proliferator-activated receptor gamma in neuron-like PC12 and B104 cells, activation with traditional agonists mimics the RhoA-inhibiting properties of ibuprofen and promotes neurite elongation in primary neurons exposed to axonal growth inhibitors, small interfering RNA against the receptor blocks RhoA suppression by those agonists, and selective receptor inhibition prevents the effect of ibuprofen on RhoA activity and neurite growth, supporting an essential role for the receptor in coupling ibuprofen to RhoA inhibition. Condition category: normal nutrient_topic: Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. plain_language: The drug reaches a growth-blocking switch in neurons through a fat-sensing receptor, not through prostaglandins. organism: Rat tissue_or_cell_type: Neurons experimental_model: Neuron-like PC12 and B104 cells and primary cultured neurons with small interfering RNA knockdown limitations: The knockdown and the selective antagonist together make the receptor requirement a test rather than a correlation. Cell lines and primary culture rather than an animal. exposure: Ibuprofen with peroxisome proliferator-activated receptor gamma agonists, antagonists and knockdown evidence_span: {"source_cache": "artifacts/ibuprofen-research/20089905.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77e2dbb010dcee44bd66645ec26cb844d7041ea4930f6373ae5dd6b10da37df3", "start_char": 0, "end_char": 1812, "text_sha256": "77e2dbb010dcee44bd66645ec26cb844d7041ea4930f6373ae5dd6b10da37df3"} [ibu-p20089905] A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. (2010). https://pubmed.ncbi.nlm.nih.gov/20089905/ DOI: 10.1523/jneurosci.5045-09.2010
    Complete structured claim and evidence

What acts on it

  1. Luteolin occupied the PPAR gamma ligand pocket in an inactive conformer; myristic acid simultaneously occupied the pocket.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    PPAR gamma ligand-binding-domain crystallography.
    limitations
    Simulated cooperative stabilization is not demonstrated nutritional synergy.
    nutrient_topic
    Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
    plain_language
    Two ligands fit in the structural preparation.
    primary_references
    Mode of peroxisome proliferator-activated receptor γ activation by luteolin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22391103/ · DOI 10.1124/mol.111.076216

    Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 364–370

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · PPAR gamma ligand-binding-domain crystallography. · source_derived_draft · unverified_draft

    ## luteolin-pparg-ligand Two ligands fit in the structural preparation. Luteolin occupied the PPAR gamma ligand pocket in an inactive conformer; myristic acid simultaneously occupied the pocket. Model: PPAR gamma ligand-binding-domain crystallography. Limitations: Simulated cooperative stabilization is not demonstrated nutritional synergy. Evidence access: Primary abstract Mode of peroxisome proliferator-activated receptor γ activation by luteolin. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22391103/ · DOI 10.1124/mol.111.076216
    Complete structured claim and evidence
  2. Mangiferin increased PPAR-gamma expression in the chondrocyte experiment.

    Mangiferin → Human PPAR gamma / PPARG source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/mangiferin-research/27734234.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44", "start_char": 0, "end_char": 1007, "text_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44"}
    experimental_model
    IL-1beta-stimulated osteoarthritis chondrocytes with inhibitor perturbation
    exposure
    Mangiferin with IL-1beta; PPAR-gamma inhibitor GW9662
    limitations
    Cell experiment, not a clinical arthritis trial; inhibitor reversal supports involvement but not direct receptor agonism.
    nutrient_topic
    Mangiferin research collection; topical membership is not evidence of a direct dietary effect. · Mangiferin
    organism
    Homo sapiens
    plain_language
    A transcriptional regulator participated in the response.
    primary_references
    [mangiferin-p27734234] Mangiferin Inhibits IL-1β-Induced Inflammatory Response by Activating PPAR-γ in Human Osteoarthritis Chondrocytes. (2017). https://pubmed.ncbi.nlm.nih.gov/27734234/ DOI: 10.1007/s10753-016-0451-y
    tissue_or_cell_type
    Cultured chondrocytes

    Mangiferin: metabolism, signaling and nutrient connections (2026-09-17) · lines 1316–1327

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · IL-1beta-stimulated osteoarthritis chondrocytes with inhibitor perturbation · source_derived_draft · unverified_draft

    ### mangiferin-pparg Mangiferin increased PPAR-gamma expression in the chondrocyte experiment. Condition category: normal nutrient_topic: Mangiferin research collection; topical membership is not evidence of a direct dietary effect. plain_language: A transcriptional regulator participated in the response. organism: Homo sapiens tissue_or_cell_type: Cultured chondrocytes experimental_model: IL-1beta-stimulated osteoarthritis chondrocytes with inhibitor perturbation limitations: Cell experiment, not a clinical arthritis trial; inhibitor reversal supports involvement but not direct receptor agonism. exposure: Mangiferin with IL-1beta; PPAR-gamma inhibitor GW9662 evidence_span: {"source_cache": "artifacts/mangiferin-research/27734234.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44", "start_char": 0, "end_char": 1007, "text_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44"} [mangiferin-p27734234] Mangiferin Inhibits IL-1β-Induced Inflammatory Response by Activating PPAR-γ in Human Osteoarthritis Chondrocytes. (2017). https://pubmed.ncbi.nlm.nih.gov/27734234/ DOI: 10.1007/s10753-016-0451-y
    Complete structured claim and evidence
  3. Surface-plasmon-resonance assays detected binding of astaxanthin to recombinant human PPAR-gamma ligand-binding domains.

    Astaxanthin → Human PPAR gamma / PPARG source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary full text, methods 2.4 and SPR results
    experimental_model
    Recombinant human receptor-domain biochemistry.
    limitations
    Reporter effects depend on construct, cell and coactivator context.
    nutrient_topic
    Astaxanthin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Astaxanthin
    plain_language
    Direct binding and the direction of transcriptional effects are separate questions.
    primary_references
    The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22707263/ · DOI 10.1002/mnfr.201100798

    Astaxanthin: transport, membrane chemistry, signaling and nutrient interactions (2026-09-19) · lines 254–260

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human receptor-domain biochemistry. · source_derived_draft · unverified_draft

    ## astaxanthin-pparg-binding Direct binding and the direction of transcriptional effects are separate questions. Surface-plasmon-resonance assays detected binding of astaxanthin to recombinant human PPAR-gamma ligand-binding domains. Model: Recombinant human receptor-domain biochemistry. Limitations: Reporter effects depend on construct, cell and coactivator context. Evidence access: Primary full text, methods 2.4 and SPR results The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22707263/ · DOI 10.1002/mnfr.201100798
    Complete structured claim and evidence
  4. Adding c9,t11 CLA increased PPAR-gamma and several target-gene transcripts relative to vehicle.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Primary cultures of differentiating human preadipocytes.
    limitations
    Not proof of improved insulin sensitivity in humans.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    The other isomer gave a different transcriptional response.
    primary_references
    Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12730300/ · DOI 10.1194/jlr.M300001-JLR200

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 94–100

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Primary cultures of differentiating human preadipocytes. · source_derived_draft · unverified_draft

    ## cla-pparg-expression-c9 The other isomer gave a different transcriptional response. Adding c9,t11 CLA increased PPAR-gamma and several target-gene transcripts relative to vehicle. Model: Primary cultures of differentiating human preadipocytes. Limitations: Not proof of improved insulin sensitivity in humans. Evidence access: Primary abstract Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12730300/ · DOI 10.1194/jlr.M300001-JLR200
    Complete structured claim and evidence
  5. Adding t10,c12 CLA lowered PPAR-gamma and several target-gene transcripts.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Primary cultures of differentiating human preadipocytes.
    limitations
    Expression and direct ligand binding are different measurements.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    A regulator of fat-cell identity was suppressed.
    primary_references
    Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12730300/ · DOI 10.1194/jlr.M300001-JLR200

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 86–92

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Primary cultures of differentiating human preadipocytes. · source_derived_draft · unverified_draft

    ## cla-pparg-expression-t10 A regulator of fat-cell identity was suppressed. Adding t10,c12 CLA lowered PPAR-gamma and several target-gene transcripts. Model: Primary cultures of differentiating human preadipocytes. Limitations: Expression and direct ligand binding are different measurements. Evidence access: Primary abstract Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12730300/ · DOI 10.1194/jlr.M300001-JLR200
    Complete structured claim and evidence
  6. Adding t10,c12 CLA increased PPAR-gamma and ERK1/2 phosphorylation before PPAR-gamma protein declined.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human adipocyte time-course experiments.
    limitations
    ERK causation of the PPAR-gamma phosphorylation was proposed rather than isolated here.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Signaling changed before the regulator became less abundant.
    primary_references
    Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18287349/ · DOI 10.1093/jn/138.3.455

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 110–116

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human adipocyte time-course experiments. · source_derived_draft · unverified_draft

    ## cla-pparg-phosphorylation Signaling changed before the regulator became less abundant. Adding t10,c12 CLA increased PPAR-gamma and ERK1/2 phosphorylation before PPAR-gamma protein declined. Model: Human adipocyte time-course experiments. Limitations: ERK causation of the PPAR-gamma phosphorylation was proposed rather than isolated here. Evidence access: Primary abstract Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18287349/ · DOI 10.1093/jn/138.3.455
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Each drug tested produced concentration-dependent activation of peroxisome proliferator-activated receptor alpha and gamma isoforms and of peroxisomal fatty acyl-CoA beta-oxidase activity, with a rank order of stereoselectivity for alpha activation and fatty acyl oxidase stimulation of S(+)-ibuprofen greater than R(-)-ibuprofen, S(+)-ibuprofen being more potent than indomethacin and naproxen on these parameters, while on gamma the order was S(+)-naproxen greater than indomethacin greater than S(+)-ibuprofen greater than R(-)-ibuprofen.

    S(+)-ibuprofen → Human PPAR alpha / PPARA source_derived_draftungraded
    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/ibuprofen-research/11755111.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1dd77f4a1eebd7777285c424b1731f4744d0fa593e62cfbde0a92dbb6242b239", "start_char": 0, "end_char": 2074, "text_sha256": "1dd77f4a1eebd7777285c424b1731f4744d0fa593e62cfbde0a92dbb6242b239"}
    experimental_model
    Reporter and enzyme assays comparing ibuprofen isomers against naproxen and indomethacin across four readouts
    exposure
    S(+)- and R(-)-ibuprofen compared directly on cyclooxygenase-1 and -2, platelet function and nuclear receptor activation
    limitations
    The only record here that measures both enantiomers on the same panel, which is what makes the fold-differences meaningful. Several different assay systems are combined.
    nutrient_topic
    Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. · Ibuprofen
    organism
    Rat, human and sheep systems
    plain_language
    Both hands switch on the fat-handling nuclear receptors, with a much smaller gap between them than at cyclooxygenase.
    primary_references
    [ibu-p11755111] Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin. (2001). https://pubmed.ncbi.nlm.nih.gov/11755111/ DOI: 10.1016/s0006-2952(01)00822-x
    tissue_or_cell_type
    Transfected cells, hepatoma cells, platelets and purified enzyme

    Ibuprofen: the enantiomer that works, the one that was called inactive, the one-way chemistry that turns one into the other, and the targets that are not cyclooxygenase (2026-09-22) · lines 331–342

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Reporter and enzyme assays comparing ibuprofen isomers against naproxen and indomethacin across four readouts · source_derived_draft · unverified_draft

    ### ibu-both-isomers-hit-ppar Each drug tested produced concentration-dependent activation of peroxisome proliferator-activated receptor alpha and gamma isoforms and of peroxisomal fatty acyl-CoA beta-oxidase activity, with a rank order of stereoselectivity for alpha activation and fatty acyl oxidase stimulation of S(+)-ibuprofen greater than R(-)-ibuprofen, S(+)-ibuprofen being more potent than indomethacin and naproxen on these parameters, while on gamma the order was S(+)-naproxen greater than indomethacin greater than S(+)-ibuprofen greater than R(-)-ibuprofen. Condition category: normal nutrient_topic: Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. plain_language: Both hands switch on the fat-handling nuclear receptors, with a much smaller gap between them than at cyclooxygenase. organism: Rat, human and sheep systems tissue_or_cell_type: Transfected cells, hepatoma cells, platelets and purified enzyme experimental_model: Reporter and enzyme assays comparing ibuprofen isomers against naproxen and indomethacin across four readouts limitations: The only record here that measures both enantiomers on the same panel, which is what makes the fold-differences meaningful. Several different assay systems are combined. exposure: S(+)- and R(-)-ibuprofen compared directly on cyclooxygenase-1 and -2, platelet function and nuclear receptor activation evidence_span: {"source_cache": "artifacts/ibuprofen-research/11755111.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1dd77f4a1eebd7777285c424b1731f4744d0fa593e62cfbde0a92dbb6242b239", "start_char": 0, "end_char": 2074, "text_sha256": "1dd77f4a1eebd7777285c424b1731f4744d0fa593e62cfbde0a92dbb6242b239"} [ibu-p11755111] Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin. (2001). https://pubmed.ncbi.nlm.nih.gov/11755111/ DOI: 10.1016/s0006-2952(01)00822-x
    Complete structured claim and evidence
  2. GW9662 reversed the anti-inflammatory effect of mangiferin in the chondrocyte study.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_span
    {"source_cache": "artifacts/mangiferin-research/27734234.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44", "start_char": 0, "end_char": 1007, "text_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44"}
    experimental_model
    IL-1beta-stimulated osteoarthritis chondrocytes with inhibitor perturbation
    exposure
    Mangiferin with IL-1beta; PPAR-gamma inhibitor GW9662
    limitations
    The indexed abstract reports reversal of anti-inflammatory effects collectively; endpoint-specific magnitude is unresolved.
    nutrient_topic
    Mangiferin research collection; topical membership is not evidence of a direct dietary effect. · Mangiferin
    organism
    Homo sapiens
    plain_language
    Blocking related machinery weakened the response.
    primary_references
    [mangiferin-p27734234] Mangiferin Inhibits IL-1β-Induced Inflammatory Response by Activating PPAR-γ in Human Osteoarthritis Chondrocytes. (2017). https://pubmed.ncbi.nlm.nih.gov/27734234/ DOI: 10.1007/s10753-016-0451-y
    tissue_or_cell_type
    Cultured chondrocytes
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Mangiferin: metabolism, signaling and nutrient connections (2026-09-17) · lines 1342–1353

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · IL-1beta-stimulated osteoarthritis chondrocytes with inhibitor perturbation · source_derived_draft · unverified_draft

    ### mangiferin-pparg-loss GW9662 reversed the anti-inflammatory effect of mangiferin in the chondrocyte study. Condition category: machinery_impairment nutrient_topic: Mangiferin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Blocking related machinery weakened the response. organism: Homo sapiens tissue_or_cell_type: Cultured chondrocytes experimental_model: IL-1beta-stimulated osteoarthritis chondrocytes with inhibitor perturbation limitations: The indexed abstract reports reversal of anti-inflammatory effects collectively; endpoint-specific magnitude is unresolved. exposure: Mangiferin with IL-1beta; PPAR-gamma inhibitor GW9662 evidence_span: {"source_cache": "artifacts/mangiferin-research/27734234.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44", "start_char": 0, "end_char": 1007, "text_sha256": "1b9924d15171028fb1006c5e72c7b0dc6742d96f6873a292e6f5741061ad2f44"} [mangiferin-p27734234] Mangiferin Inhibits IL-1β-Induced Inflammatory Response by Activating PPAR-γ in Human Osteoarthritis Chondrocytes. (2017). https://pubmed.ncbi.nlm.nih.gov/27734234/ DOI: 10.1007/s10753-016-0451-y
    Complete structured claim and evidence
  3. Astaxanthin increased PPAR-gamma and catalase expression in challenged AGS cells; the PPAR-gamma antagonist GW9662 suppressed the ROS/IL-8 protective response.

    Astaxanthin → Human catalase / CAT source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human AGS expression assays and pharmacological inhibition.
    limitations
    Antagonist sensitivity is not direct binding evidence or a demonstration of iron deficiency rescue.
    nutrient_topic
    Astaxanthin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Astaxanthin
    plain_language
    A receptor-linked antioxidant enzyme response contributed in this model.
    primary_references
    Astaxanthin Inhibits Mitochondrial Dysfunction and Interleukin-8 Expression in Helicobacter pylori-Infected Gastric Epithelial Cells. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30231525/ · DOI 10.3390/nu10091320

    Astaxanthin: transport, membrane chemistry, signaling and nutrient interactions (2026-09-19) · lines 302–308

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human AGS expression assays and pharmacological inhibition. · source_derived_draft · unverified_draft

    ## astaxanthin-gastric-catalase A receptor-linked antioxidant enzyme response contributed in this model. Astaxanthin increased PPAR-gamma and catalase expression in challenged AGS cells; the PPAR-gamma antagonist GW9662 suppressed the ROS/IL-8 protective response. Model: Human AGS expression assays and pharmacological inhibition. Limitations: Antagonist sensitivity is not direct binding evidence or a demonstration of iron deficiency rescue. Evidence access: Primary abstract Astaxanthin Inhibits Mitochondrial Dysfunction and Interleukin-8 Expression in Helicobacter pylori-Infected Gastric Epithelial Cells. · 2018 · https://pubmed.ncbi.nlm.nih.gov/30231525/ · DOI 10.3390/nu10091320
    Complete structured claim and evidence
  4. PGC-1 mRNA expression is dramatically elevated on cold exposure in both brown fat and skeletal muscle, and PGC-1 greatly increases the transcriptional activity of PPARgamma and the thyroid hormone receptor on the UCP1 promoter.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/cold-research/9529258.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8986da918d7bde4d0314f51038ee3b1c6413042a1132bb6fbf55ceeb54e79ddf", "start_char": 0, "end_char": 842, "text_sha256": "8986da918d7bde4d0314f51038ee3b1c6413042a1132bb6fbf55ceeb54e79ddf"}
    experimental_model
    Cloning of PGC-1 from a brown fat cDNA library with ectopic expression in white adipose cells
    exposure
    Cold exposure of mice; ectopic PGC-1 expression
    limitations
    The founding description of the coactivator. Ectopic expression shows sufficiency in white fat cells; it does not establish the size of the contribution in vivo.
    nutrient_topic
    Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. · Cold water immersion
    organism
    Mouse
    plain_language
    Cold turns on a coactivator that switches the heat gene on through two different receptors.
    primary_references
    [cold-p9529258] A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. (1998). https://pubmed.ncbi.nlm.nih.gov/9529258/ DOI: 10.1016/s0092-8674(00)81410-5
    tissue_or_cell_type
    Brown fat and skeletal muscle

    Cold water immersion: cold sensing, heat production, the catecholamine axis and what repeated exposure changes (2026-09-19) · lines 338–349

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cloning of PGC-1 from a brown fat cDNA library with ectopic expression in white adipose cells · source_derived_draft · unverified_draft

    ### cold-pgc1a-cold-induction PGC-1 mRNA expression is dramatically elevated on cold exposure in both brown fat and skeletal muscle, and PGC-1 greatly increases the transcriptional activity of PPARgamma and the thyroid hormone receptor on the UCP1 promoter. Condition category: normal nutrient_topic: Cold water immersion research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake. plain_language: Cold turns on a coactivator that switches the heat gene on through two different receptors. organism: Mouse tissue_or_cell_type: Brown fat and skeletal muscle experimental_model: Cloning of PGC-1 from a brown fat cDNA library with ectopic expression in white adipose cells limitations: The founding description of the coactivator. Ectopic expression shows sufficiency in white fat cells; it does not establish the size of the contribution in vivo. exposure: Cold exposure of mice; ectopic PGC-1 expression evidence_span: {"source_cache": "artifacts/cold-research/9529258.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "8986da918d7bde4d0314f51038ee3b1c6413042a1132bb6fbf55ceeb54e79ddf", "start_char": 0, "end_char": 842, "text_sha256": "8986da918d7bde4d0314f51038ee3b1c6413042a1132bb6fbf55ceeb54e79ddf"} [cold-p9529258] A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. (1998). https://pubmed.ncbi.nlm.nih.gov/9529258/ DOI: 10.1016/s0092-8674(00)81410-5
    Complete structured claim and evidence
  5. BRL co-treatment rescued FABP4, LPL and perilipin transcripts but did not prevent reduced GLUT4, glucose uptake or triglyceride content.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    One-week co-treatment of primary human adipocyte cultures.
    limitations
    Transcript rescue did not restore all downstream functions.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Restoring some target genes did not restore the whole response.
    primary_references
    Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18287349/ · DOI 10.1093/jn/138.3.455

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 118–124

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · One-week co-treatment of primary human adipocyte cultures. · source_derived_draft · unverified_draft

    ## cla-partial-rescue Restoring some target genes did not restore the whole response. BRL co-treatment rescued FABP4, LPL and perilipin transcripts but did not prevent reduced GLUT4, glucose uptake or triglyceride content. Model: One-week co-treatment of primary human adipocyte cultures. Limitations: Transcript rescue did not restore all downstream functions. Evidence access: Primary abstract Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18287349/ · DOI 10.1093/jn/138.3.455
    Complete structured claim and evidence
  6. Adding t10,c12, but not c9,t11 CLA, suppressed ligand-stimulated PPAR-gamma reporter activation.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Primary human adipocyte culture and reporter experiments.
    limitations
    The 2003 transient-transfection study reported antagonism with both isomers; assay context remains relevant.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    An isomer could interfere with activation of the regulator.
    primary_references
    Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18287349/ · DOI 10.1093/jn/138.3.455

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 102–108

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Primary human adipocyte culture and reporter experiments. · source_derived_draft · unverified_draft

    ## cla-pparg-antagonism An isomer could interfere with activation of the regulator. Adding t10,c12, but not c9,t11 CLA, suppressed ligand-stimulated PPAR-gamma reporter activation. Model: Primary human adipocyte culture and reporter experiments. Limitations: The 2003 transient-transfection study reported antagonism with both isomers; assay context remains relevant. Evidence access: Primary abstract Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18287349/ · DOI 10.1093/jn/138.3.455
    Complete structured claim and evidence
  7. p65 siRNA depletion attenuated CLA-induced loss of GLUT4 and PPAR-gamma proteins and suppression of glucose uptake.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human adipocyte RNA-interference experiment.
    limitations
    Supports a contribution in this model, not universal necessity in all tissues.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    Removing a signaling component weakened the adverse response.
    primary_references
    Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16155293/ · DOI 10.1074/jbc.M508159200

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 142–148

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human adipocyte RNA-interference experiment. · source_derived_draft · unverified_draft

    ## cla-rela-knockdown Removing a signaling component weakened the adverse response. p65 siRNA depletion attenuated CLA-induced loss of GLUT4 and PPAR-gamma proteins and suppression of glucose uptake. Model: Human adipocyte RNA-interference experiment. Limitations: Supports a contribution in this model, not universal necessity in all tissues. Evidence access: Primary abstract Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. · 2005 · https://pubmed.ncbi.nlm.nih.gov/16155293/ · DOI 10.1074/jbc.M508159200
    Complete structured claim and evidence
  8. CLA increased TFF3 in human SW480 cells; PPAR-gamma antagonist GW9662 prevented this induction.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human colorectal cell line, 0–2.5 micromolar CLA.
    limitations
    Pharmacological support does not identify the active isomer or prove human mucosal healing.
    nutrient_topic
    CLA collection; isomer, preparation, species, exposure and manipulation remain explicit. · Conjugated linoleic acid / CLA isomer family
    plain_language
    A mucosal-repair protein responded through a receptor-sensitive pathway.
    primary_references
    Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23077197/ · DOI 10.3945/jn.112.163931

    Conjugated linoleic acid: isomers, signaling, nutrient interactions and discovery (2026-09-19) · lines 374–380

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human colorectal cell line, 0–2.5 micromolar CLA. · source_derived_draft · unverified_draft

    ## cla-tff3 A mucosal-repair protein responded through a receptor-sensitive pathway. CLA increased TFF3 in human SW480 cells; PPAR-gamma antagonist GW9662 prevented this induction. Model: Human colorectal cell line, 0–2.5 micromolar CLA. Limitations: Pharmacological support does not identify the active isomer or prove human mucosal healing. Evidence access: Primary abstract Dietary conjugated linoleic acid activates PPARγ and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate sodium-induced colitis. · 2012 · https://pubmed.ncbi.nlm.nih.gov/23077197/ · DOI 10.3945/jn.112.163931
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards